$ANGX

Sarowitz Steven I purchased $47K of ANGX

Sarowitz Steven I purchased 10,979 shares of Angel Studios, Inc. (ANGX) at $4.27 on 2026-09-01.

Original reporting
SEC EDGAR · Sarowitz Steven I
Published Sep 3, 2026, 8:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 8:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ANGX
Neutral
high confidence
Mentioned
$ANGX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ANGXNeutralLow
01

Why it matters

The purchase adds to insider ownership but is too small to affect market perception significantly.

02

Market read

Minor insider purchase; limited trading relevance.

03

What to watch

Potential upcoming financing round or strategic partnership not disclosed.

Relevance 4/10Novelty 3/10Timing: filing date 2026-09-03

Background

SEC Form 4 filing discloses insider transactions; this is the first public report of the purchase.

Company-level read

Ticker impact

$ANGXNeutralHigh confidence
Context

Director Sarowitz Steven I bought 10,979 shares of Angel Studios for $46,925.34 on 2026-09-01, increasing his holdings to 752,204 shares.

Expected impact

minimal impact, price likely unchanged

Evidence & confidence

The transaction size (~$47k) is modest relative to market cap; director purchases are generally viewed as a neutral signal.

Market effects

None; Angel Studios operates in media/entertainment, but the trade is too small to affect sector.

None; US-listed micro‑cap, limited broader market relevance.

None

Counterpoint

If the director is signaling confidence, a modest buy could precede a positive catalyst.

Key entities

  • Angel Studios, Inc.

    US-listed media company (NASDAQ: ANGX).

  • Sarowitz Steven I

    Director of Angel Studios.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ANGXMed

Angel Reports Second Quarter 2026 Results: Guild Membership Climbs 99.2% Year-Over-Year

Angel Studios, Inc. (ANGX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Angel Reports Second Quarter 2026 Results: Guild Membership Climbs 99.2% Year-Over-Year ~ Guild Revenue of $90.7 Million, Up 93.8% Year-Over-Year ~ ~ Guild Selling & Marketing Expense Falls to 52.8% of Guild Revenue in Q2 2026, Reduced from 71.6% in Q2 2025 ~ ​ PROVO

$ANGXMed

B. Riley Lifts PT on Angel Studios (ANGX) – Here’s Why

B. Riley raised its price target on Angel Studios (NYSE:ANGX) to $8 from $7 and kept a Buy rating on June 30. The firm cited higher fiscal Q2 estimates tied to paying Guild members and said Angel Studios may benefit from an improved film slate, including Young Washington’s theater debut. Angel Studios reported fiscal Q1 2026 revenue up 143% to $115.1 million.